Perrigo Co PLC (PRGO)

91.39
NYSE : Health Care
Prev Close 91.08
Day Low/High 90.10 / 91.79
52 Wk Low/High 84.85 / 198.42
Avg Volume 2.38M
Exchange NYSE
Shares Outstanding 143.22M
Market Cap 13.04B
P/E Ratio N/A
Div & Yield 0.58 (0.60%)

Latest News

It's Time to Sell These 5 Big Stocks This Summer

It's Time to Sell These 5 Big Stocks This Summer

Owning these stocks could be toxic to your portfolio.

Perrigo Announces Leadership Change In Rx Pharmaceuticals Segment

Perrigo Announces Leadership Change In Rx Pharmaceuticals Segment

Appoints John Wesolowski as Acting General Manager, Rx Pharmaceuticals

July 18 Deadline Alert: Law Offices Of Howard G. Smith Reminds Investors Of The Upcoming Deadline In The Class Action Lawsuit Against Perrigo Company Plc

July 18 Deadline Alert: Law Offices Of Howard G. Smith Reminds Investors Of The Upcoming Deadline In The Class Action Lawsuit Against Perrigo Company Plc

Law Offices of Howard G. Smith reminds investors of the upcoming  July 18, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class") of investors who purchased...

Jim Cramer's 'Mad Money' Recap: Stock Prices Just Getting Started

Jim Cramer's 'Mad Money' Recap: Stock Prices Just Getting Started

Listen to what the companies are actually telling you. Then assess what that might mean for the future, Cramer says.

Pricing Stress may Weigh on Generic Drugmakers Ahead of Q2 Earnings

Pricing Stress may Weigh on Generic Drugmakers Ahead of Q2 Earnings

Endo Pharmaceuticals is most under pressure, analysts say.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Perrigo Company Plc Of Class Action Lawsuit And A Lead Plaintiff Deadline Of July 18, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Perrigo Company Plc Of Class Action Lawsuit And A Lead Plaintiff Deadline Of July 18, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Perrigo Company plc ("Perrigo") (NYSE: PRGO) between April 21,...

Bill Ackman's Pershing Square Fund Goes Into the Red

Bill Ackman's Pershing Square Fund Goes Into the Red

Valeant Pharmaceuticals is not letting up on Ackman's fund, dragging 2016 losses down by more than 20%.

PRGO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Perrigo Company Plc And A Lead Plaintiff Deadline Of July 18, 2016

PRGO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Perrigo Company Plc And A Lead Plaintiff Deadline Of July 18, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Perrigo Company plc ("Perrigo") (NYSE: PRGO) securities...

DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Perrigo Company Plc To Contact The Firm

DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Perrigo Company Plc To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Perrigo Company Plc Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 18, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Perrigo Company Plc Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 18, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Perrigo Company plc ("Perrigo") (NYSE: PRGO) between April 21,...

SHAREHOLDER NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Perrigo Company Plc And Reminds Investors With Losses To Contact The Firm

SHAREHOLDER NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Perrigo Company Plc And Reminds Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO).

INVESTOR ALERT: Investigation Of Perrigo Company Plc Announced By Law Offices Of Howard G. Smith

INVESTOR ALERT: Investigation Of Perrigo Company Plc Announced By Law Offices Of Howard G. Smith

Law Offices of Howard G. Smith announces an investigation on behalf of investors of Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO) concerning the Company and its officers' possible violations of federal...

Valeant Enlists Former Tyco Exec for More Help With Accounting

Valeant Enlists Former Tyco Exec for More Help With Accounting

The appointment of Sam Eldessouky is the latest move by the Canadian drugmaker to regain its reputation from a financial reporting standpoint.

Perrigo Sells Vitamins Business to IVC

Perrigo Sells Vitamins Business to IVC

The transaction follows a Houlihan Lokey-run sale process for the drugmaker's private-label nutraceuticals unit that was started after Mylan NV's takeover attempt was rebuffed.

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Perrigo Company Plc And A Lead Plaintiff Deadline Of July 18, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Perrigo Company Plc And A Lead Plaintiff Deadline Of July 18, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Perrigo Company plc ("Perrigo") (NYSE: PRGO) securities...

Looking for Relief From Biotech Pain

A lost leader in Celgene and a Perrigo rumor have put a scare in the charts.

Perrigo (PRGO) Stock Retreats as Takeover Speculation Fades

Perrigo (PRGO) Stock Retreats as Takeover Speculation Fades

Perrigo (PRGO) stock is declining this afternoon after Raymond James contended that there are 'few natural buyers' for the company following yesterday's takeover speculation.

Perrigo Rises Further as Takeover Rumor Swirls

Perrigo Rises Further as Takeover Rumor Swirls

With no outright denial of the story to kill it, Perrigo's share rose further in Tel Aviv overnight on a day-old rumor of a $20 billion takeover deal.